Wells Fargo & Company Caribou Biosciences, Inc. Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 43,229 shares of CRBU stock, worth $87,322. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,229
Previous 41,607
3.9%
Holding current value
$87,322
Previous $68,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$9.33 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$9.23 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$8.7 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$4.76 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $123M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...